Magnetar Medical Devices Ltd.
Patent pending 3rd generation electrical transdermal patch with therapeutic delivery of insulins Lantus and Apidra in humans.
Lean Startup developing improved 3rd generation transdermal patches using a patent pending low-resistance route through the skin. May also have an application in defibrillation. Over 60 trials in Phase 0 subjects, over 500 individual in vitro trials.